Cargando…

New Perspectives on Desensitization in the Current Era - An Overview

Blood group and tissue incompatibilities remain significant barriers to achieving transplantation. Although no patient should be labeled “un-transplantable” due to blood group or tissue incompatibility, all candidates should be provided with individualized and realistic counseling regarding their an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Vineeta, Locke, Jayme E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363260/ https://www.ncbi.nlm.nih.gov/pubmed/34394089 http://dx.doi.org/10.3389/fimmu.2021.696467

Ejemplares similares

Editorial: Sensitization and Desensitization in Organ Transplantation
por: Anwar, Imran J., et al.
Publicado: (2021)

Current Desensitization Strategies in Heart Transplantation
por: Habal, Marlena V.
Publicado: (2021)

Current Approaches to Desensitization in Solid Organ Transplantation
por: Schinstock, Carrie, et al.
Publicado: (2021)

Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization
por: Choi, Ashley Y., et al.
Publicado: (2021)

Sensitization and Desensitization in Vascularized Composite Allotransplantation
por: Moris, Dimitrios, et al.
Publicado: (2021)

Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current Perspectives
por: Jeffery, Hannah C., et al.
Publicado: (2016)

Normal Graft Function After Pig-to-Human Kidney Xenotransplant
por: Locke, Jayme E., et al.
Publicado: (2023)

Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: The Role of Desensitizations
por: Castells, Mariana
Publicado: (2017)

A20 Restricts Inflammatory Response and Desensitizes Gingival Keratinocytes to Apoptosis
por: Li, Yajie, et al.
Publicado: (2020)

Case Report: Rapid Desensitization to Ocrelizumab for Multiple Sclerosis Is Effective and Safe
por: Aun, Marcelo Vivolo, et al.
Publicado: (2022)

Successful Desensitization to the Radiocontrast Material Iohexol (Omnipaque™)
por: Saad, Abeer, et al.
Publicado: (2022)

Xenotransplantation: A New Era
por: Carrier, Amber N., et al.
Publicado: (2022)

HLA Desensitization in Solid Organ Transplantation: Anti-CD38 to Across the Immunological Barriers
por: Joher, Nizar, et al.
Publicado: (2021)

The Hygiene Hypothesis and New Perspectives—Current Challenges Meeting an Old Postulate
por: Garn, Holger, et al.
Publicado: (2021)

Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives
por: Peyraud, Florent, et al.
Publicado: (2022)

Impact of Sex in the Efficacy of Perioperative Desensitization Procedures in Heart Transplantation: A Retrospective Cohort Study
por: Nguyen, Lee S., et al.
Publicado: (2021)

Current Sarcoidosis Models and the Importance of Focusing on the Granuloma
por: Locke, Landon W., et al.
Publicado: (2020)

History of Envenoming Therapy and Current Perspectives
por: Pucca, Manuela B., et al.
Publicado: (2019)

Aspects of the Complement System in New Era of Xenotransplantation
por: Miyagawa, Shuji, et al.
Publicado: (2022)

A modified perioperative regimen for deceased donor kidney transplantation in presensitized recipients without prior desensitization therapy
por: Guo, Zhiliang, et al.
Publicado: (2023)

Cancer drug delivery in the nano era: An overview and perspectives
por: Li, Zhen, et al.
Publicado: (2017)

Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation
por: Morath, Christian, et al.
Publicado: (2020)

Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies
por: Alcayaga-Miranda, Francisca, et al.
Publicado: (2017)

Triple Therapy for Cystic Fibrosis (Elexacaftor, Tezacaftor, and Ivacaftor): Desensitization After Skin Rash
por: Santos, Ana Isabel, et al.
Publicado: (2023)

Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
por: Wirth, Thomas C., et al.
Publicado: (2017)

Interferon and Hepatitis B: Current and Future Perspectives
por: Ye, Jianyu, et al.
Publicado: (2021)

Mechanical circulatory support in the new era: an overview
por: Shekar, Kiran, et al.
Publicado: (2016)

Autoimmune Addison's Disease as Part of the Autoimmune Polyglandular Syndrome Type 1: Historical Overview and Current Evidence
por: Perniola, Roberto, et al.
Publicado: (2021)

New-age vaccine adjuvants, their development, and future perspective
por: Verma, Shailendra Kumar, et al.
Publicado: (2023)

mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy
por: Deng, Zhuoya, et al.
Publicado: (2022)

Autophagy and Rheumatoid Arthritis: Current Knowledges and Future Perspectives
por: Vomero, Marta, et al.
Publicado: (2018)

Lactobacillus spp. for Gastrointestinal Health: Current and Future Perspectives
por: Dempsey, Elaine, et al.
Publicado: (2022)

Drug desensitization in the coronavirus disease 2019 pandemic era: Local success to widespread potential
por: Blumenthal, Kimberly G., et al.
Publicado: (2021)

Successful desensitization in a patient with hypersensitivity to multiple insulin preparations - case report
por: Petricău, Carina, et al.
Publicado: (2021)

New insight into the role of fibroblasts in the epithelial immune microenvironment in the single-cell era
por: Wang, Liangzhe, et al.
Publicado: (2023)

Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective
por: Suryavanshi, Santosh V., et al.
Publicado: (2021)

Peptidylarginine Deiminase 2 in Host Immunity: Current Insights and Perspectives
por: Wu, Zhenyu, et al.
Publicado: (2021)

Editorial: Radiation and the Immune System: Current Knowledge and Future Perspectives
por: Lumniczky, Katalin, et al.
Publicado: (2018)

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
por: Thomas, Remy, et al.
Publicado: (2018)

Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
por: Guo, Zong Sheng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kq42mln5qvafe1gat6bb4vrtjq